LOCHMÜLLER LAB

We are a highly collaborative group and our research is founded on strong partnerships with leading investigators, academic groups, patient organizations and pharmaceutical and biotech..... Although individually uncommon, rare diseases are so numerous that they collectively affect as many as one person in every 17 - in Canada, about 2 million people. Our research program focuses on defining the basic molecular and cellular mechanisms that cause neuromuscular disorders, to enable improved diagnosis, better care and development of effective treatments... We focus on scientific, genetic and clinical research into rare neuromuscular disorders and clinical care for patients with these conditions. We aim to understand why small variations in the human genome lead to these frequently disabling, sometimes lethal, and rarely treatable conditions affecting the musculature and nervous system. Our group has a bench-to-bedside translational approach, from identifying underlying genetic defects in..

Primary location: Ottawa Canada